Literature DB >> 23546628

A herbal formula for prevention of influenza-like syndrome: a double-blind randomized clinical trial.

Lai-Yi Wong1, Ping-Chung Leung, Suet-Yee Pang, King-Fai Cheng, Chun-Kwok Wong, Wai-Kei Lam, Kwok-Pui Fung, Tak-Fai Lau, Yee-Kit Tse, Chi-Yui Kwok.   

Abstract

OBJECTIVE: To investigate the efficacy of a herbal formula in the prevention of influenza or influenza-like syndrome among elderies residing in old-people's home in Hong Kong. The secondary objectives are to investigate the quality of life (QOL) and symptomology changes among the herbal users and to evaluate the safety of this formula.
METHODS: In ten old people's home or community centres in New Territories, Hong Kong, 740 eligible subjects agreed to join the study and were randomized to receive a herbal formula or a placebo on alternate days over 8 weeks. Among those 740 participants, 113 had provided blood samples for immunological assessments before and after the study drug. Assessments were done at 0, 4, 8 and 12 weeks. Participants were instructed to keep a daily record of body temperature and any symptoms as sore throat, myalgia, running nose or cough, and to report to assessor accordingly. Those reporting body temperature of 37.8 °C and above would be visited and a proper nasopharyngeal swab be taken for viral study.
RESULTS: Seventy-two participants developed influenza-like-symptoms but none of them was proven influenza in their nasopharyngeal swabs, 40 of these patients belonged to the herbal group and 32 to the placebo group, without significant differences between groups. The difference on the changes in QOL between the two groups was not statistically significant. However, in the immunological study, the natural killer cell absolute count was significantly increased in the herbal group compared with the placebo group (463 ± 253 vs 413 ± 198, P<0.05).
CONCLUSIONS: The herbal preparation was not effective compared with placebo in the prevention of influenza-like syndrome. It was however safe and possibly supporting immunological responses.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23546628      PMCID: PMC7088916          DOI: 10.1007/s11655-012-1269-6

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  11 in total

1.  A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community.

Authors:  Trang Vu; Stephen Farish; Mark Jenkins; Heath Kelly
Journal:  Vaccine       Date:  2002-03-15       Impact factor: 3.641

2.  [Clinical observation on 103 patients of severe acute respiratory syndrome treated by integrative traditional Chinese and Western Medicine].

Authors:  Lin Lin; Yun Han; Zhi-min Yang
Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi       Date:  2003-06

3.  Cost-effectiveness of influenza vaccination for elderly people living in the community.

Authors:  C M Schooling; L C Wong; J Chau; A Cheung; A Ho; S M McGhee
Journal:  Hong Kong Med J       Date:  2009-10       Impact factor: 2.227

4.  Tests of scaling assumptions and construct validity of the Chinese (HK) version of the SF-36 Health Survey.

Authors:  C L Lam; B Gandek; X S Ren; M S Chan
Journal:  J Clin Epidemiol       Date:  1998-11       Impact factor: 6.437

5.  The use of an herbal formula by hospital care workers during the severe acute respiratory syndrome epidemic in Hong Kong to prevent severe acute respiratory syndrome transmission, relieve influenza-related symptoms, and improve quality of life: a prospective cohort study.

Authors:  Joseph T F Lau; P C Leung; E L Y Wong; C Fong; K F Cheng; S C Zhang; C W K Lam; V Wong; K M Choy; W M Ko
Journal:  J Altern Complement Med       Date:  2005-02       Impact factor: 2.579

6.  Mortality associated with influenza and respiratory syncytial virus in the United States.

Authors:  William W Thompson; David K Shay; Eric Weintraub; Lynnette Brammer; Nancy Cox; Larry J Anderson; Keiji Fukuda
Journal:  JAMA       Date:  2003-01-08       Impact factor: 56.272

7.  Influenza A (H5N1) in Hong Kong: an overview.

Authors:  John S Tam
Journal:  Vaccine       Date:  2002-05-15       Impact factor: 3.641

8.  The public's acceptance of novel vaccines during a pandemic: a focus group study and its application to influenza H1N1.

Authors:  N Henrich; B Holmes
Journal:  Emerg Health Threats J       Date:  2010-03-26

9.  Acceptability of A/H1N1 vaccination during pandemic phase of influenza A/H1N1 in Hong Kong: population based cross sectional survey.

Authors:  Joseph T F Lau; Nelson C Y Yeung; K C Choi; Mabel Y M Cheng; H Y Tsui; Sian Griffiths
Journal:  BMJ       Date:  2009-10-27

10.  Willingness of Hong Kong healthcare workers to accept pre-pandemic influenza vaccination at different WHO alert levels: two questionnaire surveys.

Authors:  Josette S Y Chor; Karry L K Ngai; William B Goggins; Martin C S Wong; Samuel Y S Wong; Nelson Lee; Ting-fan Leung; Timothy H Rainer; Sian Griffiths; Paul K S Chan
Journal:  BMJ       Date:  2009-08-25
View more
  4 in total

1.  Analysis on the Chinese medicine syndromes and demographic characteristics of patients with influenza-like illness in clinics of China.

Authors:  Ai-hua Ou; Chuan-jian Lu; Ji-qiang Li; Xiao-yan Li; Ze-huai Wen; Hua Deng; Su-qin Xue; Wen-wei Ouyang
Journal:  Chin J Integr Med       Date:  2014-03-06       Impact factor: 1.978

2.  Influenza and influenza-like syndromes: the subjects' beliefs, the attitude to prevention and treatment, and the impact in Italian general population.

Authors:  Roberto W Dal Negro; Alessandro Zanasi; Paola Turco; Massimiliano Povero
Journal:  Multidiscip Respir Med       Date:  2018-03-01

3.  Efficacy and safety of Chou-Ling-Dan granules in the treatment of seasonal influenza via combining Western and traditional Chinese medicine: protocol for a multicentre, randomised controlled clinical trial.

Authors:  Jiayang He; Zhengtu Li; Wanyi Huang; Wenda Guan; Hongxia Ma; Zi Feng Yang; Xinhua Wang
Journal:  BMJ Open       Date:  2019-04-02       Impact factor: 2.692

4.  Potential antiviral effects of some native Iranian medicinal plants extracts and fractions against influenza A virus.

Authors:  Parvaneh Mehrbod; Hanieh Safari; Zeinab Mollai; Fatemeh Fotouhi; Yasaman Mirfakhraei; Hanieh Entezari; Saied Goodarzi; Zahra Tofighi
Journal:  BMC Complement Med Ther       Date:  2021-10-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.